Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach

19 Aug 2020

Abstract excerpt

Multidrug-resistant Vibrio parahaemolyticus has become a significant public health concern. The development of effective drugs and vaccines against Vibrio parahaemolyticus is the current research priority. Thus, we aimed to find out effective drug and vaccine targets using a comprehensive genome-based analysis. A total of 4822 proteins were screened from V. parahaemolyticus proteome. Among 16 novel cytoplasmic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to vaccines and immunoinformatics approaches
Share to Vibrio bacteria research studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32813697
DOI: 10.1371/journal.pone.0237181

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approachPMID 32813697Read ↗

Comprehensive Genome Based Analysis of <i>Vibrio parahaemolyticus</i> for Identifying Novel Drug and Vaccine Molecules: Subtractive Proteomics and Vaccinomics ApproachSemantic proximity Read ↗

Advanced vaccinomic, immunoinformatic, and molecular modeling strategies for designing Multi- epitope vaccines against the Enterobacter cloacae complexSemantic proximity Read ↗

Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumanniiSemantic proximity Read ↗

Subtractive Proteomics and Reverse-Vaccinology Approaches for Novel Drug Target Identification and Chimeric Vaccine Development against Bartonella henselae Strain Houston-1Semantic proximity Read ↗

PBITV3 : A robust and comprehensive tool for screening pathogenic proteomes for drug targets and prioritizing vaccine candidatesSemantic proximity Read ↗

A Multi-Epitope Vaccine Design for Human Pasteurellosis using Outer Membrane β-barrel Proteins of <i>Pasteurella multocida</i>Semantic proximity Read ↗

Design of a Multi-epitope Vaccine Against Human Glanders Targeting Outer Membrane β-barrel Proteins of <i>Burkholderia mallei</i>Semantic proximity Read ↗

Designing a multi-epitope vaccine against the Lassa virus through reverse vaccinology, subtractive proteomics, and immunoinformatics approachesSemantic proximity Read ↗

Proteome Exploration of <i>Legionella pneumophila</i> for Identifying Novel Therapeutics: A Hierarchical Subtractive Genomics and Reverse Vaccinology ApproachSemantic proximity Read ↗

VacSol: a high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinologySemantic proximity Read ↗

Proteome level analysis of drug-resistant Prevotella melaninogenica for the identification of novel therapeutic candidatesSemantic proximity Read ↗

Identification of a Potential Vaccine against Treponema pallidum Using Subtractive Proteomics and Reverse-Vaccinology ApproachesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.